Diagnostic Value of Cardiac Troponin I in Acute Myocardial Infarction: A Clinical Study

Abstract

This study aims to clarify the diagnostic value and clinical importance of troponin I in identifying heart diseases, particularly in emergency settings. The study comprised 116 adults, aged 35 to 80 years, who presented with symptoms indicative of heart disease. Participants with chronic kidney disease or recent trauma were excluded to prevent confounding results. Venous blood samples were analyzed for troponin I levels using an electrochemiluminescence immunoassay. The findings revealed that 82.8% of participants had normal troponin levels, while 17.2% exhibited elevated levels. The highest frequency of elevated troponin was observed in the 40–59 age group. Furthermore, males accounted for 55% of the elevated cases compared to 45% for females. The results confirm that cardiac troponin I serves as a highly specific and sensitive biomarker for detecting myocardial injury. Its integration into clinical protocols enables timely diagnosis and improved patient management in cases of acute myocardial infarction.